DYAX: Dyax Corp. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DYAX: Dyax Corp.

DYAX 38.41

0.0%

Jan 25 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (21)	8/20/2001 1:41:57 AM
From: aknahow	Read Replies (1) of 197

Xoma CEO said this on web cast last Friday. "With the partnerships with Bax, Onyx, and DNA, and the 28 licensees of cell expression technology, and with "all phase display companies shortly to become licensees" Have no idea if he is correct, nor what shortly means nor how many "phage" companies there are. Any ideas about approximately how many there are would be appreciated. While XOMA remains one of the most disdained stocks by the S.I. biotech experts, mutual funds have increased holdings from about 2% to around 50% as of June 30, 2001.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next